Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2011 Nov;22(11):1545-52.
doi: 10.1007/s10552-011-9831-7. Epub 2011 Sep 14.

Serum total and HDL cholesterol and risk of prostate cancer

Alison M Mondul  1 , Stephanie J Weinstein, Jarmo Virtamo, Demetrius Albanes
Affiliations
Randomized Controlled Trial

Serum total and HDL cholesterol and risk of prostate cancer

Alison M Mondul et al. Cancer Causes Control. 2011 Nov.

Abstract

Background: Studies suggest a decreased risk of high-grade prostate cancer in men with lower circulating total cholesterol and that statins may protect against aggressive disease. Confirmation in additional populations and examination of associations for lipoprotein subfractions are needed.

Methods: We examined prostate cancer risk and serum total and HDL cholesterol in the ATBC Study cohort (n = 29,093). Cox proportional hazards models were used to estimate the relative risk of total (n = 2,041), non-aggressive (n = 829), aggressive (n = 461), advanced (n = 412), and high-grade (n = 231) prostate cancer by categories of total and HDL cholesterol.

Results: After excluding the first 10 years of follow-up, men with higher serum total cholesterol were at increased risk of overall (≥240 vs. <200 mg/dl: HR = 1.22, 95% CI 1.03-1.44, p-trend = 0.01) and advanced (≥240 vs. <200 mg/dl: HR = 1.85, 95% CI 1.13-3.03, p-trend = 0.05) prostate cancer. Higher HDL cholesterol was suggestively associated with a decreased risk of prostate cancer regardless of stage or grade.

Conclusions: In this population of smokers, high serum total cholesterol was associated with higher risk of advanced prostate cancer, and high HDL cholesterol suggestively reduced the risk of prostate cancer overall. These results support previous studies and, indirectly, support the hypothesis that statins may reduce the risk of advanced prostate cancer by lowering cholesterol.

PubMed Disclaimer

References

    1. Platz EA, Clinton SK, Giovannucci E. Association between plasma cholesterol and prostate cancer in the PSA era. International journal of cancer. Journal international du cancer. 2008;123(7):1693–98. - PMC - PubMed
    1. Platz EA, Till C, Goodman PJ, et al. Men with low serum cholesterol have a lower risk of high grade prostate cancer in the Prostate Cancer Prevention Trial. Cancer epidemiology, biomarkers & prevention. 2009 in press. - PMC - PubMed
    1. Mondul AM, Clipp SL, Helzlsouer KJ, Platz EA. Association between plasma total cholesterol concentration and incident prostate cancer in the CLUE II cohort. Cancer Causes Control. 21(1):61–8. Available from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop.... - PMC - PubMed
    1. Shannon J, Tewoderos S, Garzotto M, et al. Statins and prostate cancer risk: a case-control study. American Journal of Epidemiology. 2005;162(4):318–25. - PubMed
    1. Platz EA, Leitzmann MF, Visvanathan K, et al. Statin Drugs and Risk of Advanced Prostate Cancer. Journal of the National Cancer Institute. 2006;98(24):1819–25. - PubMed

Publication types